Literature DB >> 16522369

Intra-aortic injection of propofol prevents spinal cord injury during aortic surgery.

Hajime Kumagai1, Mitsuhiro Isaka, Yuji Sugawara, Kenji Okada, Katsuhiko Imai, Kazumasa Orihashi, Taijiro Sueda.   

Abstract

OBJECTIVE: We investigated whether propofol, a widely used anesthetic, injected into clamped aortic segments quickly attenuated transcranial spinal motor-evoked potential (MEP) amplitudes and protected against spinal cord injury during thoracoabdominal aortic surgery.
METHODS: Eighteen beagle dogs were divided into three groups (n=6, each group): group 1 (20 ml of saline, intra-aortic injection), group 2 (1.5 mg/kg of propofol, intravenous injection), and group 3 (1.5 mg/kg of propofol, intra-aortic injection). Aortic cross-clamping was performed for 30 min. In each group, MEP amplitudes were recorded before, during, and after aortic cross-clamping. Tarlov score and histopathological examination were used to evaluate the protective effects of intra-aortic propofol injections.
RESULTS: MEP amplitudes in group 3 attenuated to a value that was 60% of the control in just a minute after aortic cross-clamping, but maintained 40% of the control value during aortic cross-clamping. However, MEP amplitudes in groups 1 and 2 gradually attenuated and almost disappeared. Groups 1 and 2 amplitudes were lower than those in group 3, 30 min after aortic cross-clamping (p<0.001). Twenty-four hours after ischemia, the Tarlov score in group 3 was 3.5+/-0.5 and was higher than scores from groups 1 and 2, which were 0.5+/-0.5 and 1.3+/-1.2 (mean+/-SD, p<0.001, and p<0.001), respectively. Histopathologically, normal spinal cord motor neurons in group 3 were preserved to a significantly greater extent than in groups 1 and 2 (p=0.0031, and p=0.0282, respectively). There was a strong correlation between Tarlov scores at 24h and the number of normal motor neurons in the anterior horns of spinal cords (r=0.897; p<0.001).
CONCLUSIONS: Intra-aortic propofol injections produce the quick suppression of MEP amplitudes and protect spinal cords from ischemia during aortic cross-clamping.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16522369     DOI: 10.1016/j.ejcts.2006.01.042

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  5 in total

1.  Histological Findings After Aortic Cross-Clamping in Preclinical Animal Models.

Authors:  Hamdy Awad; Alexander Efanov; Jayanth Rajan; Andrew Denney; Bradley Gigax; Peter Kobalka; Hesham Kelani; D Michele Basso; John Bozinovski; Esmerina Tili
Journal:  J Neuropathol Exp Neurol       Date:  2021-10-26       Impact factor: 3.685

2.  Preconditioning of isoflurane on spinal cord ischemia can increase the number of inducible nitric oxide synthase-expressing motor neurons in rat.

Authors:  Yun-Hee Sung; Sang-Hak Lee; Joon-Kyung Sung; Jin-Hee Han; Hong Kim; Chang-Ju Kim; Jong-Man Kang
Journal:  Korean J Anesthesiol       Date:  2010-01-31

3.  Propofol Inhibits Ischemia/Reperfusion-Induced Cardiotoxicity Through the Protein Kinase C/Nuclear Factor Erythroid 2-Related Factor Pathway.

Authors:  Shengqiang Li; Zhen Lei; Meng Zhao; Yonghao Hou; Di Wang; Xingli Xu; Xiaowen Lin; Jingxin Li; Shuhai Tang; Jingui Yu; Tao Meng
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

4.  Propofol injection combined with bone marrow mesenchymal stem cell transplantation better improves electrophysiological function in the hindlimb of rats with spinal cord injury than monotherapy.

Authors:  Yue-Xin Wang; Jing-Jing Sun; Mei Zhang; Xiao-Hua Hou; Jun Hong; Ya-Jing Zhou; Zhi-Yong Zhang
Journal:  Neural Regen Res       Date:  2015-04       Impact factor: 5.135

5.  In Vivo Neuroprotective Effect of Histidine-Tryptophan-Ketoglutarate Solution in an Ischemia/Reperfusion Spinal Cord Injury Animal Model.

Authors:  Shin Kwang Kang; Min-Woong Kang; Youn Ju Rhee; Cuk-Seong Kim; Byeong Hwa Jeon; Sung Joon Han; Hyun Jin Cho; Myung Hoon Na; Jae-Hyeon Yu
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2016-08-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.